FDA.reportPublic FDA data

oteseconazole 150 MG Oral Capsule

RxCUI
2602582
RxNorm name
oteseconazole 150 MG Oral Capsule
Display name
oteseconazole 150 MG Oral Capsule
Full name
oteseconazole 150 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VIVJOAOTESECONAZOLEMycovia Pharmaceuticals, Inc.e21d5008-800e-4417-927f-14340341865f2026-01-08Warnings, Adverse reactionsExact identifier
rxcui: 2602582

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e21d5008-800e-4417-927f-14340341865foteseconazole 150 MG Oral CapsuleSCD5These highlights do not include all the information needed to use VIVJOA™ safely and effectively. See full prescribing information for VIVJOA™. VIVJOA™ (oteseconazole) capsules, for oral use Initial U.S. Approval: 202220260108
e21d5008-800e-4417-927f-14340341865foteseconazole 150 MG Oral CapsulePSN5These highlights do not include all the information needed to use VIVJOA™ safely and effectively. See full prescribing information for VIVJOA™. VIVJOA™ (oteseconazole) capsules, for oral use Initial U.S. Approval: 202220260108